Earlier investigations not only found IL-2 application to be effective in treating bladder cancer, but also showed the expression of the interleukin-2 receptor (IL-2R) on many different tissue cell lines of the body [12,13,14,15,16,17,18]. The gene discussed is IL2; the disease is urinary bladder cancer.